Loading…
Eotaxin‐2 activates chemotaxis‐related events and release of reactive oxygen species via pertussis toxin‐sensitive G proteins in human eosinophils
Eosinophils play an important role in allergic and autoimmune diseases. They are activated by distinct chemokines, leading to the immigration into the inflamed tissue, and mediate tissue damage by releasing reactive oxygen species. Recently, eotaxin was found to have the broadest spectrum of activit...
Saved in:
Published in: | European journal of immunology 1998-07, Vol.28 (7), p.2152-2158 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c4042-3fb6a570d8cf2c6c4643ccbdb841e4923d22abf917111e866f079dc5f5e799583 |
container_end_page | 2158 |
container_issue | 7 |
container_start_page | 2152 |
container_title | European journal of immunology |
container_volume | 28 |
creator | Elsner, Jörn Petering, Holger Kluthe, Christof Kimmig, Daniela Smolarski, Regina Ponath, Paul Kapp, Alexander |
description | Eosinophils play an important role in allergic and autoimmune diseases. They are activated by distinct chemokines, leading to the immigration into the inflamed tissue, and mediate tissue damage by releasing reactive oxygen species. Recently, eotaxin was found to have the broadest spectrum of activities of all eosinophil‐activating CC chemokines. In this study we investigated the effect of the novel CC chemokine, eotaxin‐2, on eosinophil effector functions and compared its activity with eotaxin. Using nitrobenzoxadiazole‐phallacidin staining and flow cytometry, we show that eotaxin‐2 induced rapid and transient actin polymerization, a prerequisite for cell migration and modulation of the respiratory burst, in eosinophils in the same range of efficacy as observed for eotaxin. Eotaxin‐2 induced the release of reactive oxygen species in a dose‐dependent manner; half maximal and maximal release were found at 50 ng/ml and 500 ng/ml, respectively. Surprisingly, the efficacy of eotaxin‐2 was comparable to that of eotaxin and C5a. Release of reactive oxygen species was inhibited by pertussis toxin, indicating the involvement of Gi proteins in the signaling of eotaxin‐2. Moreover, the anti‐CC chemokine receptor 3 (CCR3) monoclonal antibody, 7B11, was able to inhibit transient rise in the cytosolic Ca2+ concentration and the release of reactive oxygen species following stimulation with eotaxin‐2. Therefore, eotaxin‐2 represents a potent CC chemokine for human eosinophils activating chemotaxis‐related events, such as actin polymerization, and the respiratory burst via the CCR3. Moreover, the efficacy of eotaxin‐2 seems to be in the same range as that of eotaxin which might re‐evaluate the recent profile of activity of CC chemokines in the activation of human eosinophils. |
doi_str_mv | 10.1002/(SICI)1521-4141(199807)28:07<2152::AID-IMMU2152>3.0.CO;2-G |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80045851</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16506332</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4042-3fb6a570d8cf2c6c4643ccbdb841e4923d22abf917111e866f079dc5f5e799583</originalsourceid><addsrcrecordid>eNqFUc2O0zAYjBBoKQuPgOQT2j2k2I6T2GWFtJSlRNpVD7AXDliu84UapUnIl5TtjUfgyPPxJDhN6QWhvfhnZr6ZT5ogeMPolFHKX559yObZOYs5CwUT7IwpJWl6zuWMphfc47PZZfY2zG5uboff62hKp_PlKx4uHgST49jDYEIpEyH3w4-DJ4hfKaUqidVJcKISxaUUk-DXVd2ZO1f9_vGTE2M7tzUdILFr2OwJ9EQLpQdzAluoOiSmyomHwCCQuvDP_Zh_3-2-QEWwAeu8xdYZ0kDb9YgOSVePIQgVur18QZq27sBVSFxF1v3GVARqdFXdrF2JT4NHhSkRnh3u0-D23dXH-fvwernI5pfXoRVU8DAqVomJU5pLW3CbWJGIyNpVvpKCgVA8yjk3q0KxlDEGMkkKmqrcxkUMqVKxjE6DF6Ov3-ZbD9jpjUMLZWkqqHvUklIRy5jdK2RJTJMo4l74aRTatkZsodBN6zam3WlG9dCv1kO_eihKD0XpsV_NpR5Oj2vt-9V_-9WRpnq-1FwvvPnzwxb9agP50fpQqOc_j_x3V8Lun-R7g_-Te8SiPwLIyVU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16506332</pqid></control><display><type>article</type><title>Eotaxin‐2 activates chemotaxis‐related events and release of reactive oxygen species via pertussis toxin‐sensitive G proteins in human eosinophils</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Elsner, Jörn ; Petering, Holger ; Kluthe, Christof ; Kimmig, Daniela ; Smolarski, Regina ; Ponath, Paul ; Kapp, Alexander</creator><creatorcontrib>Elsner, Jörn ; Petering, Holger ; Kluthe, Christof ; Kimmig, Daniela ; Smolarski, Regina ; Ponath, Paul ; Kapp, Alexander</creatorcontrib><description>Eosinophils play an important role in allergic and autoimmune diseases. They are activated by distinct chemokines, leading to the immigration into the inflamed tissue, and mediate tissue damage by releasing reactive oxygen species. Recently, eotaxin was found to have the broadest spectrum of activities of all eosinophil‐activating CC chemokines. In this study we investigated the effect of the novel CC chemokine, eotaxin‐2, on eosinophil effector functions and compared its activity with eotaxin. Using nitrobenzoxadiazole‐phallacidin staining and flow cytometry, we show that eotaxin‐2 induced rapid and transient actin polymerization, a prerequisite for cell migration and modulation of the respiratory burst, in eosinophils in the same range of efficacy as observed for eotaxin. Eotaxin‐2 induced the release of reactive oxygen species in a dose‐dependent manner; half maximal and maximal release were found at 50 ng/ml and 500 ng/ml, respectively. Surprisingly, the efficacy of eotaxin‐2 was comparable to that of eotaxin and C5a. Release of reactive oxygen species was inhibited by pertussis toxin, indicating the involvement of Gi proteins in the signaling of eotaxin‐2. Moreover, the anti‐CC chemokine receptor 3 (CCR3) monoclonal antibody, 7B11, was able to inhibit transient rise in the cytosolic Ca2+ concentration and the release of reactive oxygen species following stimulation with eotaxin‐2. Therefore, eotaxin‐2 represents a potent CC chemokine for human eosinophils activating chemotaxis‐related events, such as actin polymerization, and the respiratory burst via the CCR3. Moreover, the efficacy of eotaxin‐2 seems to be in the same range as that of eotaxin which might re‐evaluate the recent profile of activity of CC chemokines in the activation of human eosinophils.</description><identifier>ISSN: 0014-2980</identifier><identifier>EISSN: 1521-4141</identifier><identifier>DOI: 10.1002/(SICI)1521-4141(199807)28:07<2152::AID-IMMU2152>3.0.CO;2-G</identifier><identifier>PMID: 9692884</identifier><language>eng</language><publisher>Weinheim: WILEY‐VCH Verlag GmbH</publisher><subject>Actins - metabolism ; Antibodies, Monoclonal - immunology ; Calcium - metabolism ; Chemokine ; Chemokine CCL24 ; Chemokine receptor ; Chemokines, CC - pharmacology ; Chemotaxis, Leukocyte ; Eosinophil ; Eosinophils - drug effects ; Eosinophils - physiology ; GTP-Binding Proteins - physiology ; Humans ; Pertussis Toxin ; Reactive Oxygen Species ; Receptors, CCR3 ; Receptors, Chemokine - physiology ; Respiratory burst ; Respiratory Burst - drug effects ; Virulence Factors, Bordetella - pharmacology</subject><ispartof>European journal of immunology, 1998-07, Vol.28 (7), p.2152-2158</ispartof><rights>1998 WILEY‐VCH Verlag GmbH, Weinheim, Fed. Rep. of Germany</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4042-3fb6a570d8cf2c6c4643ccbdb841e4923d22abf917111e866f079dc5f5e799583</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9692884$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elsner, Jörn</creatorcontrib><creatorcontrib>Petering, Holger</creatorcontrib><creatorcontrib>Kluthe, Christof</creatorcontrib><creatorcontrib>Kimmig, Daniela</creatorcontrib><creatorcontrib>Smolarski, Regina</creatorcontrib><creatorcontrib>Ponath, Paul</creatorcontrib><creatorcontrib>Kapp, Alexander</creatorcontrib><title>Eotaxin‐2 activates chemotaxis‐related events and release of reactive oxygen species via pertussis toxin‐sensitive G proteins in human eosinophils</title><title>European journal of immunology</title><addtitle>Eur J Immunol</addtitle><description>Eosinophils play an important role in allergic and autoimmune diseases. They are activated by distinct chemokines, leading to the immigration into the inflamed tissue, and mediate tissue damage by releasing reactive oxygen species. Recently, eotaxin was found to have the broadest spectrum of activities of all eosinophil‐activating CC chemokines. In this study we investigated the effect of the novel CC chemokine, eotaxin‐2, on eosinophil effector functions and compared its activity with eotaxin. Using nitrobenzoxadiazole‐phallacidin staining and flow cytometry, we show that eotaxin‐2 induced rapid and transient actin polymerization, a prerequisite for cell migration and modulation of the respiratory burst, in eosinophils in the same range of efficacy as observed for eotaxin. Eotaxin‐2 induced the release of reactive oxygen species in a dose‐dependent manner; half maximal and maximal release were found at 50 ng/ml and 500 ng/ml, respectively. Surprisingly, the efficacy of eotaxin‐2 was comparable to that of eotaxin and C5a. Release of reactive oxygen species was inhibited by pertussis toxin, indicating the involvement of Gi proteins in the signaling of eotaxin‐2. Moreover, the anti‐CC chemokine receptor 3 (CCR3) monoclonal antibody, 7B11, was able to inhibit transient rise in the cytosolic Ca2+ concentration and the release of reactive oxygen species following stimulation with eotaxin‐2. Therefore, eotaxin‐2 represents a potent CC chemokine for human eosinophils activating chemotaxis‐related events, such as actin polymerization, and the respiratory burst via the CCR3. Moreover, the efficacy of eotaxin‐2 seems to be in the same range as that of eotaxin which might re‐evaluate the recent profile of activity of CC chemokines in the activation of human eosinophils.</description><subject>Actins - metabolism</subject><subject>Antibodies, Monoclonal - immunology</subject><subject>Calcium - metabolism</subject><subject>Chemokine</subject><subject>Chemokine CCL24</subject><subject>Chemokine receptor</subject><subject>Chemokines, CC - pharmacology</subject><subject>Chemotaxis, Leukocyte</subject><subject>Eosinophil</subject><subject>Eosinophils - drug effects</subject><subject>Eosinophils - physiology</subject><subject>GTP-Binding Proteins - physiology</subject><subject>Humans</subject><subject>Pertussis Toxin</subject><subject>Reactive Oxygen Species</subject><subject>Receptors, CCR3</subject><subject>Receptors, Chemokine - physiology</subject><subject>Respiratory burst</subject><subject>Respiratory Burst - drug effects</subject><subject>Virulence Factors, Bordetella - pharmacology</subject><issn>0014-2980</issn><issn>1521-4141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFUc2O0zAYjBBoKQuPgOQT2j2k2I6T2GWFtJSlRNpVD7AXDliu84UapUnIl5TtjUfgyPPxJDhN6QWhvfhnZr6ZT5ogeMPolFHKX559yObZOYs5CwUT7IwpJWl6zuWMphfc47PZZfY2zG5uboff62hKp_PlKx4uHgST49jDYEIpEyH3w4-DJ4hfKaUqidVJcKISxaUUk-DXVd2ZO1f9_vGTE2M7tzUdILFr2OwJ9EQLpQdzAluoOiSmyomHwCCQuvDP_Zh_3-2-QEWwAeu8xdYZ0kDb9YgOSVePIQgVur18QZq27sBVSFxF1v3GVARqdFXdrF2JT4NHhSkRnh3u0-D23dXH-fvwernI5pfXoRVU8DAqVomJU5pLW3CbWJGIyNpVvpKCgVA8yjk3q0KxlDEGMkkKmqrcxkUMqVKxjE6DF6Ov3-ZbD9jpjUMLZWkqqHvUklIRy5jdK2RJTJMo4l74aRTatkZsodBN6zam3WlG9dCv1kO_eihKD0XpsV_NpR5Oj2vt-9V_-9WRpnq-1FwvvPnzwxb9agP50fpQqOc_j_x3V8Lun-R7g_-Te8SiPwLIyVU</recordid><startdate>199807</startdate><enddate>199807</enddate><creator>Elsner, Jörn</creator><creator>Petering, Holger</creator><creator>Kluthe, Christof</creator><creator>Kimmig, Daniela</creator><creator>Smolarski, Regina</creator><creator>Ponath, Paul</creator><creator>Kapp, Alexander</creator><general>WILEY‐VCH Verlag GmbH</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>199807</creationdate><title>Eotaxin‐2 activates chemotaxis‐related events and release of reactive oxygen species via pertussis toxin‐sensitive G proteins in human eosinophils</title><author>Elsner, Jörn ; Petering, Holger ; Kluthe, Christof ; Kimmig, Daniela ; Smolarski, Regina ; Ponath, Paul ; Kapp, Alexander</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4042-3fb6a570d8cf2c6c4643ccbdb841e4923d22abf917111e866f079dc5f5e799583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Actins - metabolism</topic><topic>Antibodies, Monoclonal - immunology</topic><topic>Calcium - metabolism</topic><topic>Chemokine</topic><topic>Chemokine CCL24</topic><topic>Chemokine receptor</topic><topic>Chemokines, CC - pharmacology</topic><topic>Chemotaxis, Leukocyte</topic><topic>Eosinophil</topic><topic>Eosinophils - drug effects</topic><topic>Eosinophils - physiology</topic><topic>GTP-Binding Proteins - physiology</topic><topic>Humans</topic><topic>Pertussis Toxin</topic><topic>Reactive Oxygen Species</topic><topic>Receptors, CCR3</topic><topic>Receptors, Chemokine - physiology</topic><topic>Respiratory burst</topic><topic>Respiratory Burst - drug effects</topic><topic>Virulence Factors, Bordetella - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elsner, Jörn</creatorcontrib><creatorcontrib>Petering, Holger</creatorcontrib><creatorcontrib>Kluthe, Christof</creatorcontrib><creatorcontrib>Kimmig, Daniela</creatorcontrib><creatorcontrib>Smolarski, Regina</creatorcontrib><creatorcontrib>Ponath, Paul</creatorcontrib><creatorcontrib>Kapp, Alexander</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elsner, Jörn</au><au>Petering, Holger</au><au>Kluthe, Christof</au><au>Kimmig, Daniela</au><au>Smolarski, Regina</au><au>Ponath, Paul</au><au>Kapp, Alexander</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Eotaxin‐2 activates chemotaxis‐related events and release of reactive oxygen species via pertussis toxin‐sensitive G proteins in human eosinophils</atitle><jtitle>European journal of immunology</jtitle><addtitle>Eur J Immunol</addtitle><date>1998-07</date><risdate>1998</risdate><volume>28</volume><issue>7</issue><spage>2152</spage><epage>2158</epage><pages>2152-2158</pages><issn>0014-2980</issn><eissn>1521-4141</eissn><abstract>Eosinophils play an important role in allergic and autoimmune diseases. They are activated by distinct chemokines, leading to the immigration into the inflamed tissue, and mediate tissue damage by releasing reactive oxygen species. Recently, eotaxin was found to have the broadest spectrum of activities of all eosinophil‐activating CC chemokines. In this study we investigated the effect of the novel CC chemokine, eotaxin‐2, on eosinophil effector functions and compared its activity with eotaxin. Using nitrobenzoxadiazole‐phallacidin staining and flow cytometry, we show that eotaxin‐2 induced rapid and transient actin polymerization, a prerequisite for cell migration and modulation of the respiratory burst, in eosinophils in the same range of efficacy as observed for eotaxin. Eotaxin‐2 induced the release of reactive oxygen species in a dose‐dependent manner; half maximal and maximal release were found at 50 ng/ml and 500 ng/ml, respectively. Surprisingly, the efficacy of eotaxin‐2 was comparable to that of eotaxin and C5a. Release of reactive oxygen species was inhibited by pertussis toxin, indicating the involvement of Gi proteins in the signaling of eotaxin‐2. Moreover, the anti‐CC chemokine receptor 3 (CCR3) monoclonal antibody, 7B11, was able to inhibit transient rise in the cytosolic Ca2+ concentration and the release of reactive oxygen species following stimulation with eotaxin‐2. Therefore, eotaxin‐2 represents a potent CC chemokine for human eosinophils activating chemotaxis‐related events, such as actin polymerization, and the respiratory burst via the CCR3. Moreover, the efficacy of eotaxin‐2 seems to be in the same range as that of eotaxin which might re‐evaluate the recent profile of activity of CC chemokines in the activation of human eosinophils.</abstract><cop>Weinheim</cop><pub>WILEY‐VCH Verlag GmbH</pub><pmid>9692884</pmid><doi>10.1002/(SICI)1521-4141(199807)28:07<2152::AID-IMMU2152>3.0.CO;2-G</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2980 |
ispartof | European journal of immunology, 1998-07, Vol.28 (7), p.2152-2158 |
issn | 0014-2980 1521-4141 |
language | eng |
recordid | cdi_proquest_miscellaneous_80045851 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Actins - metabolism Antibodies, Monoclonal - immunology Calcium - metabolism Chemokine Chemokine CCL24 Chemokine receptor Chemokines, CC - pharmacology Chemotaxis, Leukocyte Eosinophil Eosinophils - drug effects Eosinophils - physiology GTP-Binding Proteins - physiology Humans Pertussis Toxin Reactive Oxygen Species Receptors, CCR3 Receptors, Chemokine - physiology Respiratory burst Respiratory Burst - drug effects Virulence Factors, Bordetella - pharmacology |
title | Eotaxin‐2 activates chemotaxis‐related events and release of reactive oxygen species via pertussis toxin‐sensitive G proteins in human eosinophils |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T10%3A09%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Eotaxin%E2%80%902%20activates%20chemotaxis%E2%80%90related%20events%20and%20release%20of%20reactive%20oxygen%20species%20via%20pertussis%20toxin%E2%80%90sensitive%20G%20proteins%20in%20human%20eosinophils&rft.jtitle=European%20journal%20of%20immunology&rft.au=Elsner,%20J%C3%B6rn&rft.date=1998-07&rft.volume=28&rft.issue=7&rft.spage=2152&rft.epage=2158&rft.pages=2152-2158&rft.issn=0014-2980&rft.eissn=1521-4141&rft_id=info:doi/10.1002/(SICI)1521-4141(199807)28:07%3C2152::AID-IMMU2152%3E3.0.CO;2-G&rft_dat=%3Cproquest_cross%3E16506332%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4042-3fb6a570d8cf2c6c4643ccbdb841e4923d22abf917111e866f079dc5f5e799583%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16506332&rft_id=info:pmid/9692884&rfr_iscdi=true |